The ability of mannitol to decrease cisplatin-induced nephrotoxicity in children: real or not?
- 20 November 2015
- journal article
- review article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 77 (1) , 19-26
Abstract
Platinum compounds are very effective drugs for the treatment of childhood malignancies, and their use has contributed to an increase in the long-term survival of children with cancer. Unfortunately, the risk of severe disabling effects such as nephrotoxicity is well known among children receiving cisplatin-based chemotherapy. The main pharmacodynamics and clinical characteristics of cisplatin nephrotoxicity are described in order to explore the real ability of mannitol to prevent cisplatin-related nephrotoxicity. Currently, the choice of hydration alone or hydration plus mannitol to prevent nephrotoxicity is controversial. No guidelines are available to provide recommendations on this issue either in adults or in children. Appropriate hydration remains the main fundamental strategy for reducing the risk of cisplatin-induced nephrotoxicity. In conventional treatment regimens employing doses of cisplatin of less than 100 mg/m2 in patients with normal renal function, pre- and post-hydration (3 l/m2 at least 12 h pre-cisplatin and 24 h post-cisplatin) alone should be routinely used. In higher doses, pre- and post-hydration plus mannitol should be considered in order to ensure a valid diuresis.Keywords
This publication has 36 references indexed in Scilit:
- Necrotic Concentrations of Cisplatin Activate the Apoptotic Machinery but Inhibit Effector Caspases and Interfere with the Execution of ApoptosisToxicological Sciences, 2011
- Mechanisms of Cisplatin NephrotoxicityToxins, 2010
- Organic Cation Transporter 2 Mediates Cisplatin-Induced Oto- and Nephrotoxicity and Is a Target for Protective InterventionsThe American Journal of Pathology, 2010
- Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: Relevance of age and dose as risk factorsEuropean Journal of Cancer, 2009
- A comparison of the rates of cisplatin (cDDP) - induced nephrotoxicity associated with sodium loading or sodium loading with forced diuresis as a preventative measureJournal of Oncology Pharmacy Practice, 2009
- Contribution of Organic Cation Transporter 2 (OCT2) to Cisplatin-Induced NephrotoxicityClinical Pharmacology & Therapeutics, 2009
- Renal late effects in patients treated for cancer in childhood: A report from the Children's Oncology GroupPediatric Blood & Cancer, 2008
- Cisplatin Nephrotoxicity: A ReviewThe American Journal of the Medical Sciences, 2007
- Mitochondrial density determines the cellular sensitivity to cisplatin-induced cell deathAmerican Journal of Physiology-Cell Physiology, 2005
- Clinical Pharmacokinetics and Administration of Established Platinum DrugsDrugs, 2000